Phase I/II trial of preoperative hepatic vein embolization to increase future remnant liver volume before hepatectomy.

Phase I/II trial of preoperative hepatic vein embolization to increase future remnant liver volume before hepatectomy. - Phase I/II trial of hepatic vein embolization to increase future remnant liver volume.

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000031208

Enrollment

Registered

2018-02-15

Start date

2018-01-04

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Malignant hepatobiliary tumor

Interventions

hepatic vein embolization

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1) Patients scheduled for hepatectomy in cases suspected of malignant tumor since January 2018 2) Patients over 20 years old 3) Patients for whom consent is documented for participation in this study 4) Patients who determined that the remnant liver volume is not sufficient after hepatectomy 5) Patients who underwent portal vein embolization

Exclusion criteria

Exclusion criteria: 1) Patients whose liver function and general condition deteriorated after portal vein embolization (PTPE), and hepatic vein embolization was considered difficult to perform 2) Other patients judged unsuitable as subjects by doctor's judgment

Design outcomes

Primary

Measure	Time frame
Proportion of complications after hepatic vein embolization(Phase I). Future liver remnant volume after hepatic vein embolization, and functional remnant liver volume(Phase II).	—

Countries

Japan

Contacts

Public ContactKenichiro Araki

Gunma University Hospital Department of Hepatobiliary and Pancreatic Surgery, Integrative center of general surgery

karaki@gunma-u.ac.jp027-220-8227

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026